Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) shot up 1.5% during mid-day trading on Wednesday . The company traded as high as €30.12 and last traded at €29.52. 212,726 shares traded hands during trading, an increase of 125% from the average daily volume of 94,405 shares. The stock had previously closed at €29.08.
Carl Zeiss Meditec Price Performance
The company’s 50 day moving average price is €30.51 and its 200 day moving average price is €27.62. The firm has a market capitalization of $2.75 billion, a P/E ratio of 15.78, a PEG ratio of 2.83 and a beta of 1.35.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
See Also
- Five stocks we like better than Carl Zeiss Meditec
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
